Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed6
Recruiting3
Terminated3
Other2

Role Distribution

Principal Investigator14
PI Rate100%

Activity Timeline

Clinical Trials (14)

NCT06577467Recruiting
Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
PASC Post Acute Sequelae of COVID-19
PrincipalinvestigatorStart date: 2025-03-27
NCT05350774Phase 2Enrolling By Invitation
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Microvascular ThrombosisNeuroinflammationSystemic Inflammation
PrincipalinvestigatorStart date: 2023-07-10
NCT04564287Completed
An Observational Study of Neurologic Function After COVID-19 Infection
COVID-19
PrincipalinvestigatorStart date: 2020-10-28
NCT02437110Phase 1Completed
HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
PrincipalinvestigatorStart date: 2019-04-01
NCT03239899Phase 1Completed
PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection
HIV Infections
PrincipalinvestigatorStart date: 2018-04-09
NCT02669212Not ApplicableCompleted
Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
Chronic Fatigue Syndrome
PrincipalinvestigatorStart date: 2016-10-10
NCT02435810Recruiting
Inflammatory and Infectious Diseases of the Nervous System
Brain Disease
PrincipalinvestigatorStart date: 2015-05-06
NCT01862107Terminated
Cerebrospinal Fluid Collection and Repository Storage
Nervous System Diseases
PrincipalinvestigatorStart date: 2013-07-29
NCT01875588Recruiting
Thinking and Memory Problems in People With HIV
HIV Positive
PrincipalinvestigatorStart date: 2013-07-08
NCT01019343Not ApplicableCompleted
Physiological Investigations of Movement Disorders
DystoniaMovement DisordersParkinson's Disease+2 more
PrincipalinvestigatorStart date: 2009-12-08

Showing 10 of 14 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mark Hallett, M.D.

National Institute of Neurological Disorders and Stroke (NINDS)

Related
35 trials

Shared therapeutic areas:

DystoniaMovement DisordersParkinson Disease+3 more

Worked with same sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)
Similarity Score9%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19Amyotrophic Lateral SclerosisFatigue Syndrome, Chronic+1 more
Similarity Score6%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Brain DiseasesPost-Acute COVID-19 SyndromeNervous System Diseases+1 more
Similarity Score6%

Marie Carmen Valenza, phD

Universidad de Granada

Related
25 trials

Shared therapeutic areas:

Chronic Pelvic PainParkinson DiseasePost-Acute COVID-19 Syndrome
Similarity Score5%

Ken Nedd, M.D.

GAAD Medical Research Institute Inc.

Related
20 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisHIV InfectionsParkinson Disease
Similarity Score5%

Ahmed maged, MD

Professor

Related
29 trials

Shared therapeutic areas:

Chronic Pelvic PainEndometriosis
Similarity Score3%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisParkinson Disease
Similarity Score3%

Meral Boşnak Güçlü, Prof. Dr.

Gazi University

Related
22 trials

Shared therapeutic areas:

COVID-19Parkinson Disease
Similarity Score3%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score2%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (14)

Showing 14 of 14 trials

NCT06577467PrincipalInvestigator

Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection

PASC Post Acute Sequelae of COVID-19
Recruiting
NCT05350774Phase 2PrincipalInvestigator

Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2

Microvascular ThrombosisNeuroinflammationSystemic Inflammation
Enrolling By Invitation
NCT04564287PrincipalInvestigator

An Observational Study of Neurologic Function After COVID-19 Infection

COVID-19
Completed
NCT02437110Phase 1PrincipalInvestigator

HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis
Completed
NCT03239899Phase 1PrincipalInvestigator

PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection

HIV Infections
Completed
NCT02669212Not ApplicablePrincipalInvestigator

Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health

Chronic Fatigue Syndrome
Completed
NCT02435810PrincipalInvestigator

Inflammatory and Infectious Diseases of the Nervous System

Brain Disease
Recruiting
NCT01862107PrincipalInvestigator

Cerebrospinal Fluid Collection and Repository Storage

Nervous System Diseases
Terminated
NCT01875588PrincipalInvestigator

Thinking and Memory Problems in People With HIV

HIV Positive
Recruiting
NCT01019343Not ApplicablePrincipalInvestigator

Physiological Investigations of Movement Disorders

DystoniaMovement DisordersParkinson's Disease+2 more
Completed
NCT00073801PrincipalInvestigator

Pelvic Pain in Women With Endometriosis

Chronic Pelvic PainEndometriosis
Completed
NCT01692236PrincipalInvestigator

Brain Imaging for HIV-Associated Thinking and Mood Disorders

Human Immunodeficiency VirusNeurocognitive Impairment
Terminated
NCT02527460Phase 1PrincipalInvestigator

Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection

HIV InfectionsNeurologic Disorders
Terminated
NCT07388550Phase 1PrincipalInvestigator

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

Post-Acute COVID-19 Syndrome
Not Yet Recruiting

All 14 trials loaded